These results suggest that decreased FANCJ expression increased the sensitivity of MKN45 cells to oxaliplatin, but not to 5FU, while the sensitivity was not altered in 5FU-resistant MKN45/F2R gastric cancer cells. This evidence concerns the gene BRIP1 and gastric cancer.